Status: Not yet recruiting
Urinary Bladder Matrix (UBM) Registry
The purpose of this registry is to collect real-world information on patients treated with Urinary Bladder Matrix (UBM) products. The study will evaluate patient characteristics, treatment patterns, and clinical outcomes to better understand how UBM products are used in routine clinical practice and the outcomes experienced by patients over time.
Participants needed: 300
Trial details
Age: 21+Biological sex: AllType: ObservationalSponsor: Integra LifeSciences CorporationUpdated: Sep 4, 2026Duration: 12 Months
Eligibility criteria
Adults aged ≥21 years at the time of initial urinary bladder matrix (UBM) produc... [+2]
Wound treated with a skin substitute prior to UBM treatment. [+4]